Evidence map›Paper›PMID 28560524›Full record

ArticleObesity surgery2017

Pharmacokinetics in Morbid Obesity: Influence of Two Bariatric Surgery Techniques on Paracetamol and Caffeine Metabolism.

Albert Goday Arno, Magí Farré, Jose Rodríguez-Morató, Jose M Ramon, Clara Pérez-Mañá, Esther Papaseit, Ester Civit, Klaus Langohr, Marcel Lí Carbó, David Benaiges Boix and 5 more

Open access · greenAbstract readControlled Clinical Trial
PubMed Publisher
In one paragraph

Article in Obesity surgery, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 3 pooled it
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 3 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. The influence of bariatric surgery on oral drug bioavailability in patients with obesity: A systematic review.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2019
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Albert Goday ArnoDepartment of Endocrinology and Nutrition, Hospital del Mar, Barcelona, Spain.
Magí FarréIntegrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program, IMIM, Hospital del Mar Medical Research Institute, Doctor Aiguader, 88, Office 217, 08003, Barcelona, Spain.
Jose Rodríguez-MoratóSpanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto Salud Carlos III, 28029, Madrid, Spain.
Jose M RamonSection of Gastrointestinal Surgery, Hospital del Mar, Barcelona, Spain.
Clara Pérez-MañáIntegrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program, IMIM, Hospital del Mar Medical Research Institute, Doctor Aiguader, 88, Office 217, 08003, Barcelona, Spain.
Esther PapaseitIntegrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program, IMIM, Hospital del Mar Medical Research Institute, Doctor Aiguader, 88, Office 217, 08003, Barcelona, Spain.
Ester CivitIntegrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program, IMIM, Hospital del Mar Medical Research Institute, Doctor Aiguader, 88, Office 217, 08003, Barcelona, Spain.
Klaus LangohrIntegrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program, IMIM, Hospital del Mar Medical Research Institute, Doctor Aiguader, 88, Office 217, 08003, Barcelona, Spain.
Marcel Lí CarbóIntegrative Pharmacology and Systems Neuroscience Research Group, Neurosciences Research Program, IMIM, Hospital del Mar Medical Research Institute, Doctor Aiguader, 88, Office 217, 08003, Barcelona, Spain.
David Benaiges BoixDepartment of Endocrinology and Nutrition, Hospital del Mar, Barcelona, Spain.
Olga Castañer NinoCardiovascular Risk and Nutrition Research Group, IMIM, Hospital del Mar Medical Research Institute, Dr. Aiguader 88, 08003, Barcelona, Spain.
Juana Antonia Flores Le RouxDepartment of Endocrinology and Nutrition, Hospital del Mar, Barcelona, Spain.
Manuel PeraSection of Gastrointestinal Surgery, Hospital del Mar, Barcelona, Spain.
Luis GrandeSection of Gastrointestinal Surgery, Hospital del Mar, Barcelona, Spain.
Rafael de la TorreSpanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition (CIBEROBN), Instituto Salud Carlos III, 28029, Madrid, Spain. rtorre@imim.es.ORCID http://orcid.org/0000-0002-6765-1866
Hospital Del Mar · ESUniversitat Autònoma de Barcelona · ESSpanish Biomedical Research Centre in Physiopathology of Obesity and Nutrition · ESUniversitat Pompeu Fabra · ES

Funding

Generalitat de Catalunya (ES) 2014 SGR 464Instituto de Salud Carlos III FISS ETS PI08/90638Instituto de Salud Carlos III JR14/00008Instituto de Salud Carlos III JR15/00005Instituto de Salud Carlos III JR16/00020Ministerio de Economía y Competividad MTM2015-64465-C2-1-R
6 · The paper itself

Abstract

purposeThe purpose of the study was to study the impact of the two most common bariatric surgery techniques on paracetamol pharmacokinetics (a marker of gastric emptying) and caffeine metabolism (a marker of liver function). MATERIALS AND

methodsIn the present prospective study, we studied 24 morbid obese patients before, at 4 weeks, and 6 months after having undergone sleeve gastrectomy (n = 10) or Roux-en-Y gastric bypass (n = 14). For comparative purposes, 28 healthy controls (14 normal weights and 14 overweights) were also included in the study.

resultsParacetamol pharmacokinetics was altered in the obese participants leading to lower bioavailability. Bariatric surgery resulted in faster absorption and normalized pharmacokinetic parameters, prompting an increase in paracetamol bioavailability. No differences were found between surgical procedures. In the case of caffeine, the ratio paraxanthine/caffeine did not differ between morbid obese and healthy individuals. This ratio remained unmodified after surgery, indicating that the liver function (assessed by cytochrome P450 1A2 activity) was unaffected by obesity or bariatric surgery.

conclusionsParacetamol pharmacokinetics and caffeine plasma levels are altered in severely obese patients. The two studied bariatric surgical techniques normalize paracetamol oral bioavailability without impairing the liver function (measured by cytochrome P450 1A2 activity).

Indexed as

AcetaminophenAdolescentAdultBariatric SurgeryBiomarkersCaffeineFemaleGastrectomyGastric BypassHumansInactivation, MetabolicMaleMiddle AgedObesity, MorbidWeight LossYoung AdultAcetaminophenBiomarkersCaffeineCaffeineClinical trialGastric bypassMetabolismMorbid obesityParacetamolSleeve gastrectomy

Identifiers

PMID28560524
OpenAlexW2617032066

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.